AI adoption surges in life sciences manufacturing as talent, risk, and quality pressures intensify Read more
Industry reacts to Trump’s 25 per cent tariff penalty, highlighting its implications on pharma Read more
Early Alzheimer’s patients continue to benefit from 4 yrs of LEQEMBI(R) (lecanemab-irmb) Therapy, new clinical data presented at AAIC Read more
Biomarker identification to address unmet needs of idiopathic pulmonary fibrosis treatment: GlobalData Read more